Acromegaly: Difference between revisions

No edit summary
No edit summary
Line 11: Line 11:
== Prevalence  ==
== Prevalence  ==


*The&nbsp;prevalence of acromegaly is&nbsp;approximately 40-70 cases&nbsp;per million persons.<ref name="Cordero">2.</ref><ref name="Fleseriu">4.</ref>&nbsp;<br>
*The&nbsp;prevalence of acromegaly is&nbsp;approximately 40-70 cases&nbsp;per million persons.<ref name="Cordero">2.</ref><ref name="Fleseriu">4.</ref>&nbsp;
*However, new research suggests that the prevalence may be as high as 77 cases per million persons.<ref name="Fleseriu">4.</ref>
*However, new research suggests that the prevalence may be as high as 77 cases per million persons.<ref name="Fleseriu">4.</ref>
*The annual incidence of acromegaly is approximately is 3-4 new cases per million persons.<ref name="Fleseriu">4.</ref>


== Characteristics/Clinical Presentation  ==
== Characteristics/Clinical Presentation  ==

Revision as of 00:35, 19 March 2011

&nbsp;

Welcome to PT 635 Pathophysiology of Complex Patient Problems This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Original Editors - Alex Kent from Bellarmine University's Pathophysiology of Complex Patient Problems project.

Lead Editors - Your name will be added here if you are a lead editor on this page.  Read more.

Definition/Description 
[edit | edit source]

Acromegaly is a rare systemic disease which affects the entire body.[1] It is characterized by a hypersecretion of growth hormone (GH) which the body is unable to regulate.[2] GH facilitates growth of muscles, internal organs, and bones, as well as stimulating secretion of its target hormone insulin-like growth factor 1 (IGF-1).[1] ,[3] The extremely high levels of GH and IGF-1 which typify acromegaly cause tissue enlargement and metabolic changes that result in visible deformity as well as an increase in mortality.[2][4] The disease often begins between the ages of 30 and 50, and has an insidious onset and slow progression, often delaying diagnosis until later stages of the disease.[2][3]

Prevalence[edit | edit source]

  • The prevalence of acromegaly is approximately 40-70 cases per million persons.[2][4] 
  • However, new research suggests that the prevalence may be as high as 77 cases per million persons.[4]
  • The annual incidence of acromegaly is approximately is 3-4 new cases per million persons.[4]

Characteristics/Clinical Presentation[edit | edit source]

Acromegaly affects many of the body's systems, and various signs and symptoms develop over a period of several years.[5] They range from subtle changes to notable disfigurement.[2]

Clinical Presentation[2][3][5][6]:

  • Hand and foot enlargement
  • Hyperhydrosis- increased perspiration
  • Increased skin thickness
  • Darkening and thickening of body hair
  • Frontal skull bossing- an abnormally heavy brow and prominent forehead
  • Widening of the maxilla accompanied by separation of the teeth
  • Jaw malocclusion and overbite
  • Soft tissue enlargement
  • Skeletal overgrowth and thickening causing many areas to appear swollen
  • Deep and husky voice due to thickening of cartilage in the larynx
  • Ventilatory dysfunction
  • Weight gain
  • Joint pain
  • Sleep apnea
  • Acne
  • Vision problems

 

Associated Co-morbidities[edit | edit source]

add text here

Medications[edit | edit source]

add text here

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

add text here

Etiology/Causes[edit | edit source]

add text here

Systemic Involvement[edit | edit source]

add text here

Medical Management (current best evidence)[edit | edit source]

add text here

Physical Therapy Management (current best evidence)[edit | edit source]

add text here

Alternative/Holistic Management (current best evidence)[edit | edit source]

add text here

Differential Diagnosis[edit | edit source]

add text here

Case Reports/ Case Studies[edit | edit source]

add links to case studies here (case studies should be added on new pages using the case study template)

Resources
[edit | edit source]

add appropriate resources here

Recent Related Research (from Pubmed)[edit | edit source]

see tutorial on Adding PubMed Feed

Extension:RSS -- Error: Not a valid URL: Feed goes here!!|charset=UTF-8|short|max=10

References[edit | edit source]

see adding references tutorial.

  1. 1.0 1.1 1. Vance M. Acromegaly: a fascinating pituitary disorder. Neurosurg Focus 2010;29(4):1. Cite error: Invalid <ref> tag; name "Vance" defined multiple times with different content
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2. Cordero RA, Barkan AL. Current diagnosis of acromegaly. Rev Endocr Metab Disord 2008;9:13-19. Cite error: Invalid <ref> tag; name "Cordero" defined multiple times with different content Cite error: Invalid <ref> tag; name "Cordero" defined multiple times with different content Cite error: Invalid <ref> tag; name "Cordero" defined multiple times with different content Cite error: Invalid <ref> tag; name "Cordero" defined multiple times with different content Cite error: Invalid <ref> tag; name "Cordero" defined multiple times with different content
  3. 3.0 3.1 3.2 3.Merck Manual Home Edition. Acromegaly and gigantism: pituitary gland disorders. http://www.merckmanuals.com/home/print/sec13/ch162e.html (Accessed March 11 2011). Cite error: Invalid <ref> tag; name "Merck" defined multiple times with different content Cite error: Invalid <ref> tag; name "Merck" defined multiple times with different content
  4. 4.0 4.1 4.2 4.3 4.Fleseriu M, Delashaw JB, Cook DM. Acromegaly: a review of current medical therapy and new drugs on the horizon. Neurosurg Focus 2010;29(4):E15. Cite error: Invalid <ref> tag; name "Fleseriu" defined multiple times with different content Cite error: Invalid <ref> tag; name "Fleseriu" defined multiple times with different content Cite error: Invalid <ref> tag; name "Fleseriu" defined multiple times with different content
  5. 5.0 5.1 5. Reid TJ, Post KD, Bruce JN, Kanibir MN, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clinical Endocrinology 2010;72:203-208. Cite error: Invalid <ref> tag; name "Reid" defined multiple times with different content
  6. 6.Melmed S. Acromegaly pathogenesis and treatment. J. Clin. Invest 2009;119:3189-3202.